| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +45 K | 24.4% | $5.64 | +$254 K |
| Sells | 4 | -139 K | 75.6% | $8.42 | -$1.17 M |
| Net | -3 | -94.4 K | -51.2% | -$920 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Gilmore Neil O'Neill | CEO, Director | $1.73 M | -$800 K | -31.6% | Jun 4, 2024 |
| Michelle Robertson | Evp, Chief Financial Officer | $1.16 M | May 11, 2023 | ||
| Bruce Eaton | Evp, Cbo And Cto | $815 K | -$16.1 K | -1.94% | Dec 5, 2023 |
| Linda Burkly | Evp, Chief Scientific Officer | $801 K | Mar 2, 2024 | ||
| Baisong Mei | Evp, Chief Medical Officer | $775 K | -$232 K | -23.1% | Jun 4, 2024 |
| Mark Shearman | Evp, Chief Scientific Officer | $714 K | Feb 13, 2023 | ||
| Erick Lucera | Evp, Chief Financial Officer | $656 K | -$125 K | -16.1% | May 20, 2024 |
| Jessica Hopfield | Director | $382 K | +$254 K | +198% | May 30, 2024 |
| Lisa Michaels | EVP/Chief Medical Officer | $247 K | Dec 22, 2021 | ||
| Bernadette Connaughton | Director | May 30, 2024 | |||
| James C. Mullen | CEO, Director | Apr 14, 2022 | |||
| Andrew Hirsch | Director | May 30, 2024 | |||
| David Scadden | Director | May 30, 2024 | |||
| Emma Reeve | Director | May 30, 2024 | |||
| Meeta Chatterjee | Director | May 30, 2024 | |||
| Elliott Levy | Director | May 30, 2024 | |||
| Akshay Vaishnaw | Director | May 30, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|